# A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers

> **NCT02204501** · PHASE1 · COMPLETED · sponsor: **Biota Scientific Management Pty Ltd** · enrollment: 24 (actual)

## Conditions studied

- Drug-Drug Interaction Healthy Volunteers

## Interventions

- **DRUG:** Midazolam 5mg Syrup
- **DRUG:** Vapendavir 264 mg BID
- **DRUG:** Vapendavir 528 mg QD

## Key facts

- **NCT ID:** NCT02204501
- **Lead sponsor:** Biota Scientific Management Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02204501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02204501, "A Drug-Drug Interaction Study to Evaluate the Effect of Vapendavir on the Pharmacokinetics of Midazolam in Healthy Male and Female Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02204501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*